
Nano-X Imaging Ltd. NNOX
$ 1.74
1.17%
Annual report 2024
added 04-25-2026
Nano-X Imaging Ltd. Total Assets 2011-2026 | NNOX
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Nano-X Imaging Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 219 M | 254 M | 363 M | 236 M | 11.9 M | 1.86 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 363 M | 1.86 M | 185 M |
Quarterly Total Assets Nano-X Imaging Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 363 M | - | - | - | 236 M | - | - | - | 11.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 363 M | 11.9 M | 204 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.22 | -2.57 % | $ 121 M | ||
|
Align Technology
ALGN
|
6.21 B | $ 189.61 | -0.56 % | $ 14.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.8 | 0.55 % | $ 1.73 B | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.16 | 4.85 % | $ 1.31 M | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.63 | -3.04 % | $ 39.2 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.19 | -0.12 % | $ 380 M | ||
|
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.78 | 9.58 % | $ 334 M | ||
|
LivaNova PLC
LIVN
|
2.61 B | $ 64.2 | -1.45 % | $ 3.5 B | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
132 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
129 M | $ 1.27 | -0.78 % | $ 51.7 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
Electromed
ELMD
|
53.8 M | $ 26.39 | 3.57 % | $ 223 M | ||
|
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
5.3 B | $ 94.87 | 0.52 % | $ 12.8 B | ||
|
Orthofix Medical
OFIX
|
851 M | $ 12.35 | 1.65 % | $ 489 M | ||
|
Butterfly Network
BFLY
|
256 M | $ 5.33 | 3.5 % | $ 1.13 B | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Delcath Systems
DCTH
|
124 M | $ 10.84 | 1.88 % | $ 388 M | ||
|
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.06 | 0.95 % | $ 18 M | ||
|
Insulet Corporation
PODD
|
3.19 B | $ 189.56 | -1.38 % | $ 13.3 B | ||
|
CONMED Corporation
CNMD
|
2.33 B | $ 38.34 | 2.24 % | $ 1.19 B | ||
|
Inspire Medical Systems
INSP
|
907 M | $ 56.31 | -0.07 % | $ 1.65 B | ||
|
Integer Holdings Corporation
ITGR
|
3.41 B | $ 86.02 | 1.37 % | $ 2.99 B | ||
|
PAVmed
PAVM
|
38.8 M | $ 9.0 | -1.85 % | $ 6.03 M | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 84.15 | 5.56 % | $ 49.2 B | ||
|
LENSAR
LNSR
|
71.4 M | $ 5.09 | -3.23 % | $ 60.9 M | ||
|
Sintx Technologies
SINT
|
9.51 M | $ 2.47 | -1.59 % | $ 6.85 M | ||
|
MiMedx Group
MDXG
|
343 M | $ 3.43 | 2.39 % | $ 507 M | ||
|
Stryker Corporation
SYK
|
47.8 B | $ 327.51 | -0.65 % | $ 125 B |